Celgene Announces Agreement with Nogra Pharma Limited to Develop, Commercialize GED-0301

By: via Benzinga
Celgene Corporation (NASDAQ: CELG) entered into a global license agreement with Nogra Pharma Limited, a private pharmaceutical company ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.